ClearMed
All AI in Medicine Briefingsnpj Digital Medicine
AI in MedicineReal-World Cohort4 min read

Predicting persistent fever in patients with cancer receiving antibiotics: a machine learning approach

Retrospective assessment suggested that approximately one quarter of antibiotic escalations and chest CT scans occurred in patients correctly predicted not to remain febrile, highlighting the potential contextual value of fever predictions.

Published in npj Digital MedicineEHR Cohort study + Clinical AI evaluation
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

However, clinical use should be limited to an adjunctive role rather than standalone rule-out decision-making, and prospective studies are required to evaluate safety, clinician uptake, and real-world impact.

What Changes?

AI in Medicine · Real-World Cohort

Current Standard

Conventional ai in medicine practice relies on standard-of-care monitoring and existing regimens prior to this ehr cohort study + clinical ai evaluation.

New Finding

Decision curve analysis demonstrated positive net benefit across much of the evaluated threshold range.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    Early identification of patients unlikely to remain febrile could provide additional information during clinical reassessment.

  2. 02Study Evidence

    Tested in a ehr cohort study + clinical ai evaluation at the real-world cohort stage.

  3. 03Practical Meaning

    These findings indicate that short-term fever persistence can be predicted with clinically meaningful accuracy using routine data.

What This Means for You

Decision curve analysis demonstrated positive net benefit across much of the evaluated threshold range. Retrospective assessment suggested that approximately one quarter of antibiotic escalations and chest CT scans occurred in patients correctly predicted not to remain febrile, highlighting the potential contextual value of fever predictions. These findings indicate that short-term fever persistence can be predicted with clinically meaningful accuracy using routine data. However, clinical use should be limited to an adjunctive role rather than standalone rule-out decision-making, and prospective studies are required to evaluate safety, clinician uptake, and real-world impact.

The Discovery

Persistent fever after initiating intravenous antibiotics is common in hospitalized patients with cancer and often leads to additional imaging and antimicrobial escalation. Early identification of patients unlikely to remain febrile could provide additional information during clinical reassessment. We developed and externally validated machine learning models to predict persistent fever 48-72 h after antibiotic initiation using electronic health records from two academic hospitals. Adult cancer patients with fever within 24-48 h of treatment were included. Models incorporated demographics, comorbidities, laboratory results, vital signs, and temperature patterns. The best-performing model achieved an AUROC of 0.82 (95% CI 0.79-0.84) internally and 0.78 (95% CI 0.77-0.79) externally. Temperature-related variables were the dominant predictors.

How It Works, Simply

This ai in medicine research focuses on AI model. Researchers evaluated it using an eHR Cohort study + Clinical AI evaluation at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    Early identification of patients unlikely to remain febrile could provide additional information during clinical reassessment.

  2. 02Study Evidence

    Tested in a ehr cohort study + clinical ai evaluation at the real-world cohort stage.

  3. 03Practical Meaning

    These findings indicate that short-term fever persistence can be predicted with clinically meaningful accuracy using routine data.

01

Biological Mechanism & Study Design

Study Design & Cohort

EHR Cohort study + Clinical AI evaluation

EHR Cohort study + Clinical AI evaluation · Real-World Cohort

Biological Pathway & Modality

AI model

Intervention: Predicting persistent fever in patients with cancer receiving antibiotics: a machine

02

Experimental Findings & Endpoints

Persistent fever after initiating intravenous antibiotics is common in hospitalized patients with cancer and often leads to additional imaging and antimicrobial escalation.

Early identification of patients unlikely to remain febrile could provide additional information during clinical reassessment. We developed and externally validated machine learning models to predict persistent fever 48-72 h after antibiotic initiation using electronic health records from two academic hospitals.

Adult cancer patients with fever within 24-48 h of treatment were included. Models incorporated demographics, comorbidities, laboratory results, vital signs, and temperature patterns.

The best-performing model achieved an AUROC of 0.82 (95% CI 0.79-0.84) internally and 0.78 (95% CI 0.77-0.79) externally. Temperature-related variables were the dominant predictors.

03

Clinical Translation & Practice Context

Decision curve analysis demonstrated positive net benefit across much of the evaluated threshold range.

Retrospective assessment suggested that approximately one quarter of antibiotic escalations and chest CT scans occurred in patients correctly predicted not to remain febrile, highlighting the potential contextual value of fever predictions. These findings indicate that short-term fever persistence can be predicted with clinically meaningful accuracy using routine data.

However, clinical use should be limited to an adjunctive role rather than standalone rule-out decision-making, and prospective studies are required to evaluate safety, clinician uptake, and real-world impact.

03

The Bottom Line · Clinical Pearl

“However, clinical use should be limited to an adjunctive role rather than standalone rule-out decision-making, and prospective studies are required to evaluate safety, clinician uptake, and real-world impact.”

Published in npj Digital Medicine · Current Stage: Real-World Cohort

AI in Medicine · Real-World Cohort
Study Type
EHR Cohort study + Clinical AI evaluation

EHR Cohort study + Clinical AI evaluation

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Patients with cancer receiving antibiotics: a machine learning approach
Intervention & Mechanism
Predicting persistent fever in patients with cancer receiving antibiotics: a machine

AI model

Key Limitation
AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as EHR Cohort study + Clinical AI evaluation along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

Original Publication & AMA Citation

Predicting persistent fever in patients with cancer receiving antibiotics: a machine learning approach. npj Digital Medicine. Published 2026;Oct 31. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42966761/

npj Digital Medicine

https://pubmed.ncbi.nlm.nih.gov/42966761/

Read Original Paper

Continue Reading

Related in AI in Medicine

View all AI in Medicine briefings →
AI in Medicine editorial photograph for ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study
AI IN MEDICINE · CLINICAL PRACTICE

ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study

Your Medical Records Could Reveal Your True 'Biological Age' — And Predict Your Health Future. A new AI tool, ClinicalAge, uses your existing health records to calculate your biological age, offering a powerful predictor of future health risks and lifespan.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readThe Lancet Digital Health
AI IN MEDICINE · CLINICAL PRACTICE

AI Enhances Bionic Vision Precision in Brain Implant Patient

An AI-powered system can precisely predict and generate personalized visual percepts in a blind individual with a brain implant by learning their unique cortical responses to electrical stimulation. Current bionic eye technologies, while offering some degree of visual perception, often struggle with precision, consistency, and the intuitive generation of meaningful visual information for the patient.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDaily
AI IN MEDICINE · PRECLINICAL

AI Discovers Natural Molecule for Obesity with Promising Side Effect Profile

AI-guided discovery of the natural molecule BRP offers a novel, potentially better-tolerated approach to obesity treatment than existing medications. BRP represents a potential 'Ozempic-like' treatment for obesity that may circumvent common digestive side effects and muscle loss often associated with current GLP-1 agonists.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDaily